Ability Pharma: AbilityPharma Raises 7M in Financing

AbilityPharma, a Barcelona, Spain-based biopharmaceutical company focused on the development of innovative oral autophagy-inducing anticancer compounds, raised €7M in funding. The round saw participation from CTI Life Sciences Fund, Inveready, the EIC Fund, Fitalent and CDTI Innvierte. The company intends to use the funds to finance its phase 2b clinical study of antitumor compound ABTL0812 in patients with pancreatic cancer. [...]The post AbilityPharma Raises €7M in Financing appeared first on FinSMEs.